The University of Pennsylvania is credited with developing the CAR-T cancer treatment that became Novartis' Kymriah. Now, Penn researchers are using the ...
Penn team repurposes CAR-T cancer tech to treat heart disease - FierceBiotech
Read More
Bagikan Berita Ini
0 Response to "Penn team repurposes CAR-T cancer tech to treat heart disease - FierceBiotech"
Post a Comment